Pharma BD Deal Intelligence
Pfizer Inc. / Vicuron Pharmaceuticals, Inc.
2005 · Acquisition/Merger · $1.9B · Complete
Announcement Sentiment
75
Strongly positive
Pfizer agrees to acquire Vicuron at $29.10/share cash (~$1.9B); 74% premium. Anti-infectives focus - anidulafungin, dalbavancin. Closed Sept 14, 2005.
Key facts
- Announced Jun 16, 2005
- Closed Sep 14, 2005
- Deal value $1.9B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals